Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SIM Acquisition Corp. I is a Special Purpose Acquisition Company (SPAC), also known as a blank check company, incorporated in the Cayman Islands and based in Miami, Florida. The company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, or similar business combination with one or more businesses. While it maintains the flexibility to pursue opportunities in any industry, its primary focus is on identifying and acquiring high-quality, growth-oriented companies within the healthcare sector. The company completed its initial public offering in July 2024, raising $230 million, and is listed on the Nasdaq Global Market. In early 2026, the company underwent a sponsor ownership transition, with new leadership appointed to guide its search for a target business combination.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SIM Acquisition I.